Supplementary Figures S1-S6 from G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway

Figure S1. G9a silencing suppressed cell proliferation in A549 and H1299 NSCLCs Figure S2. Cell migration and invasion was suppressed in NSCLCs treated by G9a inhibitor UNC0638 Figure S3. G9a overexpression increased cell proliferation in NSCLCs Figure S4. FAK inhibitor attenuates the enhanced cell migration and invasion by G9a overexpression Figure S5. knockdown of G9a suppressed tumor metastasis in vivo. Figure S6. NF-kappa;B signaling pathway is independent of Wnt signaling pathway.</p

Supplementary Materials and Methods from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Supplementary Materials and Methods</p

Supplementary Figure 3 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Supplementary Figure 3</p

Supplementary Table 1 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Supplementary Table 1</p

Supplementary Figure 2 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Supplementary Figure 2</p

Supplementary Figure legends from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Supplementary Figure legends</p

Supplementary Figure 1 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma

Supplementary Figure 1</p